Effect of the Crosslinking Degree on Self-Healing Poly(1,2,3-Triazolium) Adhesive.

Dynamic covalent materials are a class of polymer that could be stress-relaxation, reprocessable, and self-healing due to dynamic crosslinks in network. Dynamic crosslinks play an important role in the typical characteristic of self-healing polymers. It is meaningful to understand the effect of crosslinking degree on the properties of poly(1,2,3-triazolium) (PTAM). In this article, the dynamic covalent network of PTAM adhesive has been used to study the effect of crosslinking degree. A series of PTAM adhesive with different crosslinking degrees have been obtained by changing the amount of crosslinker. Adhesion property can first rise then fall down with the increase of crosslinking degree and the best lap-shear strength is above 20 MPa. Creep resistance and solvent resistance can be enhanced with the increase of crosslinking degree. Self-healing studies have shown that crosslinking degree can enhance the ability of self-healing, but too high crosslinking degree raises the temperature of self-healing and causes side reaction which reduces the self-healing efficiency. These results provide some insights for the influence of the crosslinking degree on the self-healing and the structural design of dynamic covalent materials.

Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon Cancer.

BACKGROUND: Natural cyclopeptide RA-XII, isolated from Rubia yunnanensis, is a promising chemotherapeutic agent for colon cancer. The photosensitizer protoporphyrin-IX attached with triphenylphosphonium (TPP) could possess mitochondria targeting capacity and exert photodynamic therapy (PDT) by inducing oxidizing damage to the mitochondria and cell apoptosis eventually. In this work, pH-sensitive liposomes were constructed to simultaneously deliver RA-XII as a chemotherapeutic drug and modified porphyrin as a mitochondria-targeting photosensitizer to treat colon cancer, and verified its mechanism of action and antitumor therapeutic efficacy. METHODS: The colon cancer targeting liposome nanoparticle RA/TPPP-Lip was synthesized using thin film hydration. The therapeutic effect and targeting ability of RA/TPPP-Lip was investigated in vitro. And use HCT116 cell allogeneic subcutaneous transplantation tumor model to investigate the anti-tumor and targeting effects of RA/TPPP-Lip in vivo. RESULTS: RA/TPPP-Lip gained the targeting ability through surface-modified HA to increase the accumulation of RA-XII and TPPP in colon cancer cells. A series of in vitro experimental results showed that TPPP produced cytotoxic ROS under laser irradiation to directly damage cell mitochondria and played a combined role with RA-XII, making RA/TPPP-Lip the best colon cancer cell growth inhibitory effect. Furthermore, in vivo antitumor experiments showed that the RA/TPPP-Lip substantially accumulated at the tumor site and efficiently repressed tumor growth in nude mice. CONCLUSION: We have successfully designed a new cancer-targeted nanomedicine platform (RA/TPPP-Lip) for the collaborative treatment of colon cancer, which can achieve the targeted continuous release of multiple therapeutic drugs. This work provides a new strategy for precise combination therapy, which may promote the further development of collaborative cancer treatment platforms.